Opko Health (OPK) Non-Current Deferred Tax Liability (2014 - 2026)
Opko Health's (OPK) quarterly Non-Current Deferred Tax Liability came in at $108.2 million in Q2 2026, down 4.5% YoY from $113.3 million in Q2 2025, and down 5.53% on a QoQ basis from $114.6 million in Q1 2026.
Opko Health (OPK) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Opko Health (OPK) has 13 years of Non-Current Deferred Tax Liability data on file, last reported at $108.2 million in Q2 2026.
- Quarterly Non-Current Deferred Tax Liability fell 4.5% year-over-year to $108.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $108.2 million (down 4.5% YoY) and the FY2025 annual result came in at $126.2 million, down 10.34% from the prior year.
- Non-Current Deferred Tax Liability fell to $108.2 million in Q2 2026, from $114.6 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $176.7 million in Q2 2022 to a low of $108.2 million in Q2 2026.
- A 5-year average of $129.0 million and a median of $127.6 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability grew 29.56% — and 2023, when it dropped 24.72%.
- Tracing OPK's Non-Current Deferred Tax Liability over 5 years: stood at $126.4 million in 2022, then rose by 0.27% to $126.8 million in 2023, then rose by 11.06% to $140.8 million in 2024, then decreased by 10.34% to $126.2 million in 2025, then decreased by 14.27% to $108.2 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $108.2 million (Q2 2026), $114.6 million (Q1 2026), and $126.2 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Opko Health | 1.01 Bn | 712.28 Mn | 80.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 108.23 Mn |
| Jun 30, 2026 | 108.23 Mn |
| Mar 31, 2026 | 114.56 Mn |
| Mar 31, 2026 | 114.56 Mn |
| Dec 31, 2025 | 126.24 Mn |
| Dec 31, 2025 | 126.24 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Sep 30, 2025 | 130.34 Mn |
| Jun 30, 2025 | 113.33 Mn |
| Jun 30, 2025 | 113.33 Mn |
| Mar 31, 2025 | 129.44 Mn |
| Mar 31, 2025 | 129.44 Mn |
| Dec 31, 2024 | 140.80 Mn |
| Dec 31, 2024 | 140.80 Mn |
| Sep 30, 2024 | 128.41 Mn |
| Sep 30, 2024 | 128.41 Mn |
| Jun 30, 2024 | 119.12 Mn |
| Jun 30, 2024 | 119.12 Mn |
| Mar 31, 2024 | 121.64 Mn |
| Mar 31, 2024 | 121.64 Mn |